Concentra Group Holdings Parent Inc header image

Concentra Group Holdings Parent Inc

CON

Equity

ISIN null / Valor 136105334

New York Stock Exchange, Inc (2025-11-20)
USD 19.46+1.20%

Concentra Group Holdings Parent Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Concentra Group Holdings Parent Inc is a leading provider of occupational health services in the United States, specializing in delivering comprehensive healthcare solutions to the workforce. Established in 1979, the company operates nearly 550 medical centers and over 150 onsite medical facilities, serving more than 50,000 patients daily. Concentra's services include workers' compensation care and direct-to-employer healthcare, focusing on workplace injury management and occupational medicine. The company employs a team of 11,000 professionals, including affiliated physicians and clinicians, who utilize evidence-based treatment practices to enhance recovery outcomes and minimize disability from work-related injuries. Concentra's longstanding expertise and collaborative approach with clients underscore its commitment to improving workforce health across the nation.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.10.2025):

Concentra Group Holdings Parent Inc reported robust financial results for the second quarter of 2025, showcasing significant revenue growth, increased patient visits, and successful integration of recent acquisitions. Additionally, the company declared a cash dividend and raised its full-year 2025 guidance, reflecting strong operational performance and strategic execution.

Revenue Growth

For Q2 2025, Concentra reported revenue of $550.8 million, representing a 15.2% increase compared to $477.9 million in Q2 2024.

Net Income and Earnings Per Share

The company achieved a net income of $46.2 million with earnings per share of $0.35. Adjusted net income attributable to the company was $47.7 million, translating to an adjusted earnings per share of $0.37.

Adjusted EBITDA

Adjusted EBITDA rose by 13.2% to $115.0 million in Q2 2025, up from $101.6 million in the same quarter last year.

Patient Visits

Patient visits totaled 3,520,320 for the quarter, averaging 55,005 visits per day. This marks a 9.5% increase in daily visits compared to Q2 2024.

Acquisitions and Expansion

Concentra successfully closed the acquisition of Pivot Onsite Innovations on June 1st, expanding its total onsite health clinics to over 400 locations. This integration supports the company's goal of delivering high-quality workplace health services nationwide.

Dividend Declaration

The Board of Directors declared a cash dividend of $0.0625 per share, payable on August 28, 2025, to shareholders of record as of August 21, 2025.

Full-Year 2025 Guidance

Concentra raised its financial outlook for 2025, now expecting revenue in the range of $2.13 billion to $2.16 billion and adjusted EBITDA between $420 million to $430 million, reflecting confidence in continued growth and operational efficiency.

Summarized from source with an LLMView Source

Key figures

-11.5%1Y
%3Y
%5Y

Performance

34.0%1Y
33.1%3Y
33.1%5Y

Volatility

Market cap

2494 M

Market cap (USD)

Daily traded volume (Shares)

787,314

Daily traded volume (Shares)

1 day high/low

20.43 / 19.96

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.42%EUR 35.45
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.60%CHF 95.34
Tecan Group Ltd.
Tecan Group Ltd. Tecan Group Ltd. Valor: 1210019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.30%CHF 133.00
Siegfried Holding Ltd
Siegfried Holding Ltd Siegfried Holding Ltd Valor: 1428449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.59%CHF 70.10
COSMO Pharmaceuticals N.V.
COSMO Pharmaceuticals N.V. COSMO Pharmaceuticals N.V. Valor: 32590356
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.97%CHF 67.40
medmix Ltd
medmix Ltd medmix Ltd Valor: 112967710
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.83%CHF 8.34
SHL Telemedicine Ltd
SHL Telemedicine Ltd SHL Telemedicine Ltd Valor: 1128957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
11.57%CHF 1.35
Fagron SA
Fagron SA Fagron SA Valor: 3425437
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.74%EUR 20.50
Coloplast A/S
Coloplast A/S Coloplast A/S Valor: 20259063
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.12%DKK 577.00
Ardent Health Partners Inc
Ardent Health Partners Inc Ardent Health Partners Inc Valor: 136301364
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.12%USD 8.64